Do you typically use NOACs or Lovenox in patients with stroke due to hypercoagulability from malignancy?
Answer from: at Community Practice
We can extrapolate from studies of venous thromboembolism associated with cancer. Apixaban (at VTE treatment dose) has been compared to dalteparin in an open-label RCT in the CARAVAGGIO trial and edoxaban was compared to dalteparin in an open-label RCT in the Hokusai VTE Cancer trial. Both painters ...
Comments
at UPMC Thank you.
at Hendricks Neurology I'm glad you brought up this question. Indeed, the...
Thank you.
I'm glad you brought up this question. Indeed, the...